Content
TerrAscend Reports 64% Reduction In Net Loss In Q1 Financial Report
Article By:
Lorimer Wilson
Read
Friday, May 10, 2024 6:15 AM EDT
TerrAscend has reported its financial results for the first quarter.
In this article: TSNDF
Curaleaf Reports 16% Reduction In Net Loss In Q1 Financial Report
Article By:
Lorimer Wilson
Read
Thursday, May 9, 2024 6:34 PM EDT
Curaleaf has evolved from an MSO to an MCO, a multi-country operator, doing business in 15 countries worldwide with the expectation of creating further separation from their peers.
Trulieve Cannabis Q1 Financial Results Impressive: Revenue Loss Reduced 30%; Adj. EBITDA Up 20%
Article By:
Lorimer Wilson
Read
Thursday, May 9, 2024 12:53 PM EDT
The Q1 financial results for Trulieve were released today and the results were impressive with a 30% reduction in its Net Income Loss and a 20% increase in its Adjusted EBITDA.
In this article: TCNNF
Elliott Wave Technical Analysis: UnitedHealth Group Inc. - Thursday, May 9
Article By:
Peter Mathers
Read
Thursday, May 9, 2024 9:50 AM EDT
The analysis aims to guide traders and investors through the expected price movements influenced by UNH’s wave patterns.
In this article: UNH
Green Thumb Q1 Financial Metrics Excel Across The Board
Article By:
Lorimer Wilson
Read
Wednesday, May 8, 2024 8:41 PM EDT
Green Thumb Industries Inc. reported its financial results today for the first quarter.
In this article: GTBIF
Verano Q1 Financial Metrics Down Across The Board
Article By:
Lorimer Wilson
Read
Wednesday, May 8, 2024 1:32 PM EDT
Verano's stock price is down 3.5% as of mid-day May 8th, 2024 but is up 13.1% YTD.
In this article: VRNOF
Bear Of The Day: CVS Health
Article By:
Jeremy Mullin
Read
Wednesday, May 8, 2024 10:41 AM EDT
The earnings miss seen last week was the first since 2015, which is making investors very nervous about what the rest of 2024 may hold.
In this article: CVS
Don't Overlook These Top Medical Stocks As Q1 Earnings Approach
Article By:
Zacks Investment Research
Read
Tuesday, May 7, 2024 3:00 AM EDT
While the tech sector has led the Q1 earnings season, investors shouldn’t overlook these top medical stocks. To that point, the growth and expansion of Ligand Pharmaceuticals, Oscar Health, and Penumbra is hard to ignore.
Oscar Health: A Beacon Amidst The Uptrend
Article By:
Tim Knight
Read
Monday, May 6, 2024 11:21 AM EDT
In these trying times of relentless upticks, I might as well celebrate one of our better long ideas, which is Oscar Health. I suggested it a couple of weeks ago, and it continues to cruise higher.
In this article: OSCR
Cannabis Stocks Dropped 19%, On Average, In Last 3 Days Of This Week
Article By:
Lorimer Wilson
Read
Saturday, May 4, 2024 5:00 PM EDT
The cannabis sector dropped 18.8% in the last 3 days and it probably has further to go, based on historical data.so the question now is how much further it will drop before stabilizing. Time will tell. Stay tuned.
Johnson & Johnson: A Healthcare Giant That's Looking More Attractive By The Day
Article By:
MoneyShow.com
Read
Saturday, May 4, 2024 1:00 PM EDT
Johnson & Johnson is the largest healthcare products firm in the world by sales, spanning pharmaceuticals, medical devices, and consumer products. Plus, its shares only look more attractive as time goes on.
In this article: JNJ
Déjà Vu: Cannabis Stocks Soared 35%, On Average, Tuesday - Here's Why
Article By:
Lorimer Wilson
Read
Thursday, May 2, 2024 11:29 AM EDT
Cannabis stocks jumped 35%, on average, Tuesday with news that the DEA plans to follow a recommendation that would de-classification marijuana to a less stringently regulated Schedule III drug that can be prescribed with a prescription.
Market Fluctuates Amid Fed Decision And Mixed Corporate Earnings And Economic Signals
Article By:
The Private Banker
Read
Thursday, May 2, 2024 6:30 AM EDT
The U.S. stock markets exhibited mixed responses on Wednesday as investors navigated through a complex landscape of disappointing corporate earnings and a slew of economic data.